Key Quantitative Figures

  • Number of shares allotted: 19,630 equity shares of ₹1.00 each
  • Previous paid-up share capital: ₹29,51,98,578 consisting of 29,51,98,578 equity shares
  • New paid-up share capital: ₹29,52,18,208 consisting of 29,52,18,208 equity shares
  • Money realized by exercise of options: ₹23,80,734

Exercise Price Details

  • 17,000 shares exercised at ₹132.072 per share
  • 2,000 shares exercised at ₹67.44 per share
  • 630 shares exercised at ₹1.00 per share

Dates and Approvals

  • Allotment date: November 13, 2026
  • Scheme details: Five-Star Associate Stock Option Scheme, 2018
  • Scheme was instituted prior to IPO and amended in line with SBEB Regulations 2021
  • Shareholder approval obtained at Extra-ordinary general meeting held on October 8, 2021
  • Scheme ratified by shareholders at Annual General Meeting held on September 16, 2023
  • In-principal approval obtained from National Stock Exchange & Bombay Stock Exchange

Capital Structure Impact

  • The allotted shares shall rank pari-passu with the existing equity shares of the Company
  • Minimal dilution effect with share capital increasing by 19,630 shares (0.07% increase)

Additional Information

  • The Company is in the process of completing listing formalities for the allotted shares
  • Earnings per share data provided for reference: Basic EPS - ₹19.33, Diluted EPS - ₹19.31 (unaudited financial results for quarter ended September 30, 2026)
  • Exercise period: Commences from vesting date and expires not later than 60 months from relevant vesting date